I sent all my correspondence with ICB to my MP regarding above.
Here is his response…….
Thank you for re-sending the attachments.Having looked further into the issue of prescribing of liothyronine more broadly, I understand that the majority of patients suffering from hypothyroidism can be treated effectively with levothyroxine alone, but I know that liothyronine is perceived to be an important medicine for a small proportion of patients in order to maintain health and wellbeing.I understand that the prescribing of liothyronine is only supported if initiated by, or considered appropriate following a review by, an NHS consultant endocrinologist.With regard to costs, in 2021, the Competitions and Markets Authority (CMA) concluded an investigation and found that pharmaceutical company Advanz charged excessive and unfair prices for supplying liothyronine tablets. The CMA fined the firms involved a total of over £100 million.As well as imposing substantial fines, the CMA’s decision makes it easier for the NHS to seek compensation for the firms’ behaviour, by way of damages, should it choose to do so. In the circumstances, I believe my previous advice remains the best way forward- that is to say that in relation to your individual complaint, if you are dissatisfied with response from the ICB (CCG), I would recommend you pursue the matter through the Parliamentary and Health Service Ombudsman. I would also recommend you follow the advice in the response of from the ICB(CCG) with regard to possible treatment options. For more information on making a complaint about the NHS to the Parliamentary and Health Service Ombudsman, please see ombudsman.org.uk/making-com...
Best wishes,
Tom
[ Edited by admin to make sure there is a space after the link and before "Best". ]